AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. ORIC
  4. [SCHEDULE 13G/A] Oric Pharmaceuticals, Inc. SEC Filing

[SCHEDULE 13G/A] Oric Pharmaceuticals, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source:

Stock ORIC logo
Oric Pharmaceuticals, Inc.

NASDAQ:ORIC

ORIC Rankings

#4235 Ranked by Market Cap
N/A Ranked by Dividends

ORIC Latest News

Aug 1, 2025
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Jul 3, 2025
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Jun 6, 2025
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 28, 2025
ORIC® Pharmaceuticals Announces Potentially Best-In-Class Preliminary Efficacy and Safety Data from Ongoing Phase 1b Trial of ORIC-944 in Combination with AR Inhibitors for the Treatment of Patients with mCRPC
May 28, 2025
ORIC® Pharmaceuticals Announces $125 Million Private Placement Financing

ORIC Latest SEC Filings

Jul 2, 2025
[Form 4] Oric Pharmaceuticals, Inc. Insider Trading Activity
Jun 24, 2025
[Form 4] Oric Pharmaceuticals, Inc. Insider Trading Activity
Jun 24, 2025
[424B3] Oric Pharmaceuticals, Inc. Prospectus Filed Pursuant to Rule 424(b)(3)
Jun 23, 2025
[Form 4] Oric Pharmaceuticals, Inc. Insider Trading Activity
Jun 23, 2025
[EFFECT] Oric Pharmaceuticals, Inc. SEC Filing

ORIC Stock Data

912.69M
76.35M
9.44%
103.74%
19.06%
Biotechnology
Pharmaceutical Preparations
United States
SOUTH SAN FRANCISCO